Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Nicholson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Peptide and Protein Research|August 1, 1991
Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregationK F Fok, S G Panzer-Knodle, N S Nicholson, et al.
Circulation|January 15, 1995
Extended inhibition of platelet aggregation with the orally active platelet inhibitor SC-54684AJ A Szalony, N F Haas, A K Salyers, et al.
Platelets|November 4, 2010
Characterization of Binding of an RGD Mimetic, [(3)H]-SC-52012, to Platelet GPIIb/IIIaS G Panzer-Knodle, P Jacqmin, J D Page, et al.
Thrombosis Research|August 15, 1994
A new method for measurement of plasma concentration of orally active glycoprotein IIb/IIIa antagonistsA K Salyers, J A Szalony, B B Taite, et al.
Circulation|September 4, 1998
Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirinL G Frederick, O D Suleymanov, J A Szalony, et al.
Journal of Medicinal Chemistry|June 25, 1993
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptorJ A Zablocki, M Miyano, R B Garland, et al.
Thrombosis Research|June 1, 1994
SC-49992--a potent and specific inhibitor of platelet aggregationN S Nicholson, S G Panzer-Knodle, L W King, et al.
American Heart Journal|May 20, 1998
Assessment of platelet function assaysN S Nicholson, S G Panzer-Knodle, N F Haas, et al.
Thrombosis Research|June 1, 1991
In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agentN S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Circulation|January 15, 1995
SC-54684A: an orally active inhibitor of platelet aggregationN S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Peptide and Protein Research|August 1, 1991
Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregationK F Fok, S G Panzer-Knodle, N S Nicholson, et al.
Circulation|January 15, 1995
Extended inhibition of platelet aggregation with the orally active platelet inhibitor SC-54684AJ A Szalony, N F Haas, A K Salyers, et al.
Platelets|November 4, 2010
Characterization of Binding of an RGD Mimetic, [(3)H]-SC-52012, to Platelet GPIIb/IIIaS G Panzer-Knodle, P Jacqmin, J D Page, et al.
Thrombosis Research|August 15, 1994
A new method for measurement of plasma concentration of orally active glycoprotein IIb/IIIa antagonistsA K Salyers, J A Szalony, B B Taite, et al.
Circulation|September 4, 1998
Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirinL G Frederick, O D Suleymanov, J A Szalony, et al.
Journal of Medicinal Chemistry|June 25, 1993
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptorJ A Zablocki, M Miyano, R B Garland, et al.
Thrombosis Research|June 1, 1994
SC-49992--a potent and specific inhibitor of platelet aggregationN S Nicholson, S G Panzer-Knodle, L W King, et al.
American Heart Journal|May 20, 1998
Assessment of platelet function assaysN S Nicholson, S G Panzer-Knodle, N F Haas, et al.
Thrombosis Research|June 1, 1991
In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agentN S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Circulation|January 15, 1995
SC-54684A: an orally active inhibitor of platelet aggregationN S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Pageof 3